These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1430089)

  • 1. The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitus.
    Davis SN; Ansiferov M; Hetherington C; Brown M; Branch WJ; Hales CN; Orskov H; Alberti KG
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1282-8. PubMed ID: 1430089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of human proinsulin on glucose turnover and intermediary metabolism.
    Davis SN; Butler PC; Brown M; Beer S; Sobey W; Hanning I; Home PD; Hales CN; Alberti KG
    Metabolism; 1991 Sep; 40(9):953-61. PubMed ID: 1895960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response characteristics of human proinsulin and insulin in non-insulin-dependent diabetic humans.
    Davis SN; Monti L; Piatti PM; Brown M; Hetherington C; Orskov H; Sobey W; Hales CN; Alberti KG
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E28-35. PubMed ID: 1636698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of subcutaneous human proinsulin on the production of 64/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man.
    Davis SN; Piatti PM; Monti L; Brown M; Hetherington C; Antsiferov M; Sobey W; Hales CN; Orskov H; Alberti KG
    Diabetes Res Clin Pract; 1993 Feb; 19(2):103-13. PubMed ID: 8472625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man.
    Davis SN; Monti L; Piatti PM; Ansiferov M; Hetherington C; Brown M; Orskov H; Branch W; Hales CN; Alberti KG
    Acta Diabetol; 1993; 30(1):29-35. PubMed ID: 8329728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of insulin on the counterregulatory response to equivalent hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Davis SN; Goldstein RE; Price L; Jacobs J; Cherrington AD
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1300-7. PubMed ID: 8077324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthetic human insulin and proinsulin have additive but not synergistic effects on total body glucose disposal.
    Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Rubenstein A; Frank B; Galloway J; Olefsky JM
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1094-8. PubMed ID: 6373809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of biosynthetic human proinsulin on carbohydrate metabolism.
    Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Bergenstal R; Polonsky K; Jaspan J; Rubenstein A; Frank B
    Diabetes; 1984 Aug; 33(8):762-70. PubMed ID: 6378699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism.
    Trevisan R; Nosadini R; Avogaro A; Lippe G; Duner E; Fioretto P; Deana R; Tessari P; Tiengo A; Velussi M
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1155-62. PubMed ID: 3517029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of biosynthetic human proinsulin on the hepatic response to glucagon in insulin-deficient diabetes.
    Cohen RM; Licinio J; Polonsky KS; Galloway JA; Frank BH; Cherrington AD; Rubenstein AH
    J Clin Endocrinol Metab; 1987 Mar; 64(3):476-81. PubMed ID: 3546347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments.
    Nauck MA; Stöckmann F; Thiery J; Ebert R; Creutzfeldt W
    Horm Metab Res Suppl; 1988; 18():60-7. PubMed ID: 3056814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance: a multifaceted metabolic syndrome. Insights gained using a low-dose insulin infusion technique.
    Krentz AJ; Nattrass M
    Diabet Med; 1996 Jan; 13(1):30-9. PubMed ID: 8741810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective suppression of hepatic glucose output by human proinsulin in the dog.
    Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus.
    Glauber HS; Henry RR; Wallace P; Frank BH; Galloway JA; Cohen RM; Olefsky JM
    N Engl J Med; 1987 Feb; 316(8):443-9. PubMed ID: 3543679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a two hour proinsulin infusion on the glucose lowering potency of a following insulin injection.
    Hübinger A; Randerath W; Tosetti P; Schlüter KJ; Gries FA
    Horm Metab Res Suppl; 1988; 18():34-7. PubMed ID: 3056809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
    Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.